Page 125 - Biomedical Engineering and Design Handbook Volume 2, Applications

104 MEDICAL DEVICE DESIGN

Humes, H. D., S. M. MacKay, et al. (1999). “Tissue engineering of a bioartificial renal tubule assist device: in
vitro transport and metabolic characteristics.” Kidney Int, 55(6):2502–14
Hurle, A., P. Llamas, et al. (1997). “Paraplegia complicating intraaortic balloon pumping.” Ann Thorac Surg,
63(4):1217–8.
Jeffrey, K. and V. Parsonnet (1998). “Cardiac pacing, 1960–1985: a quarter century of medical and industrial
innovation.” Circulation, 97(19):1978–91.
Johnson, R. J. (1994). “Complement activation during extracorporeal therapy: biochemistry, cell biology and
clinical relevance.” Nephrol Dial Transplant, 9 (Suppl 2):36–45.
Jones, C. H. (1998). “Continuous renal replacement therapy in acute renal failure: membranes for CRRT.” Artif
Organs, 22(1):2–7.
Kannan, R. Y., H. J. Salacinski, et al. (2005). “Current status of prosthetic bypass grafts: a review.” J Biomed
Mater Res B Appl Biomater, 74(1):570–81.
Kantrowitz, A. (1990). “Origins of intraaortic balloon pumping.” Ann Thorac Surg, 50(4):672–4.
Kantrowitz, A., P. S. Freed, et al. (1992). “Initial clinical trial of a closed loop, fully automatic intra-aortic bal-
loon pump.” ASAIO J, 38 (3):M617–21.
Kantrowitz, A., S. Tjonneland, et al. (1968). “Initial clinical experience with intraaortic balloon pumping in car-
diogenic shock.” JAMA, 203(2):113–8.
Kapadia, M. R., D. A. Popowich, et al. (2008). “Modified prosthetic vascular conduits.” Circulation,
117(14):1873–82.
Kasirajan, V., P. M. McCarthy, et al. (2000). “Clinical experience with long-term use of implantable left ven-
tricular assist devices: indications, implantation, and outcomes.” Semin Thorac Cardiovasc Surg,
12(3):229–37.
Kaufman, J. S. (2000). “Antithrombotic agents and the prevention of access thrombosis.” Semin Dial,
13(1):40–6.
Kirklin, J. K. and W. L. Holman (2006). “Mechanical circulatory support therapy as a bridge to transplant or
recovery (new advances).” Curr Opin Cardiol, 21(2):120–6.
Kleine, P., M. Perthel, et al. (2000). “Downstream turbulence and high intensity transient signals (HITS) follow-
ing aortic valve replacement with Medtronic Hall or St. Jude Medical valve substitutes.” Eur J Cardiothorac
Surg, 17(1):20–4.
Klinkmann, H. and J. Vienken (1995). “Membranes for dialysis.” Nephrol Dial Transplant, 10 (Suppl 3):39–45.
Kohler, T. R., J. R. Stratton, et al. (1992). “Conventional versus high-porosity polytetrafluoroethylene grafts: clin-
ical evaluation.” Surgery, 112(5):901–7.
Kolff, W. J., H. T. J. Berk, et al., (1944). “The artificial kidney: A dialyzer with a great area.” Acta Med Scanty,
117(2):121–134.
Krafczyk, M., M. Cerrolaza, et al. (1998). “Analysis of 3D transient blood flow passing through an artificial aor-
tic valve by Lattice-Boltzmann methods.” J Biomech, 31(5):453–62.
Krajcer, Z. and M. H. Howell (2000). “Update on endovascular treatment of peripheral vascular disease: new
tools, techniques, and indications.” Tex Heart Inst J, 27(4):369–85.
Kuitunen, A. H., L. J. Heikkila, et al. (1997). “Cardiopulmonary bypass with heparin-coated circuits and reduced
systemic anticoagulation.” Ann Thorac Surg, 63(2):438–44.
Kumano, H., S. Suehiro, et al. (1999). “Coagulofibrinolysis during heparin-coated cardiopulmonary bypass with
reduced heparinization.” Ann Thorac Surg, 68(4):1252–6.
Kumbasar, S. D., E. Semiz, et al. (1999). “Mechanical complications of intra-aortic balloon counterpulsation.”
Int J Cardiol, 70(1):69–73.
Kusumoto, F. M. and N. Goldschlager (1996). “Cardiac pacing.” N Engl J Med, 334(2):89–97.
L’Heureux, N., N. Dusserre, et al. (2007a). “Technology insight: the evolution of tissue-engineered vascular
grafts—from research to clinical practice.” Nat Clin Pract Cardiovasc Med, 4(7):389–95.
L’Heureux, N., T. N. McAllister, et al. (2007b). “Tissue-engineered blood vessel for adult arterial revascularization.”
N Engl J Med, 357(14):1451–3.
L’Heureux, N., S. Paquet, et al. (1998). “A completely biological tissue-engineered human blood vessel.” Faseb J,
12(1):47–56.